cannabinoid derivatives (VivaCell)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecannabinoid derivatives (VivaCell)
Drug Alias NamePPAR agonists (VivaCell)VCE-003.1VCE-004.1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator activated receptor inhibitors
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsNerve DegenerationMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmerald Health Biotechnology España SLU
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmerald Health Biotechnology España SLU
Active IndicationsN/A
Inactive IndicationsNerve DegenerationMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A